Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis
Sponsor: Beijing University of Chinese Medicine
A EARLY_PHASE1 clinical study on Chronic Atrophic Gastritis, this trial is ongoing. The trial is conducted by Beijing University of Chinese Medicine and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
Sep 2022 — Feb 2024 [monthly]
Recruiting EARLY_PHASE1
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing University of Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .